Skip to main content
OpenTrials
Recruiting

NCT Number: NCT04352036

Constitution of a Prospective Cohort of Patients With Acute Suppurative Hidrosadenitis Followed in the Great West: the COVER Cohort (Verneuil Cohort)

Our primary objective with this cohort will be to define the different phenotypes of acute hidrosadenitis, the characterization of which is essential to define suitable therapeutic approaches. Indeed, our recent data allow us to note that there would be different phenotypes of acute hidrosadenitis and therefore different pathologies inducing different follow-ups and care.

Recruiting

Interested in participating?

Request Info

Key information

Sex eligibility

All sexes

Study type

Observational

Primary location

CHU Angers, Angers, France

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patient diagnosed with acute hidrosadenitis by a dermatologist
  • Patient agreeing to be part of the study

Exclusion criteria

  • Major under guardianship
  • Protected persons

Treatment and study plan

No Interventional study

Other

no interventional study

Primary outcomes

  1. Description of the natural history and identification of the different clinical forms of acute hidrosadenitis

    Time frame: through study completion, an average of 3 years

    history of the disease, classification of Hurley, Canoui-Poitrine and van der Zee and Jemec

  2. Prevalence of severe forms (grade II, III)

    Time frame: through study completion, an average of 3 years

    Number of patients with severe disease (grades II and III)

  3. Definition of different phenotypes of acute hidrosadenitis

    Time frame: through study completion, an average of 3 years

    patient history, Canoui-Poitrine and van der Zee and Jemec classification, blood and urine tests, imaging

  4. Identify the environmental factors associated with the chronicity of the disease

    Time frame: through study completion, an average of 3 years

    socio-demographic data

  5. Identify the environmental factors associated with the chronicity of the disease

    Time frame: through study completion, an average of 3 years

    questionnaire for collecting dietary habits

  6. Identify the environmental factors associated with the chronicity of the disease

    Time frame: through study completion, an average of 3 years

    biological nutritional assessment research for a dysmetabolic syndrome

  7. Identify the environmental factors associated with the chronicity of the disease

    Time frame: through study completion, an average of 3 years

    research for a dysmetabolic syndrome

  8. Identify the environmental factors associated with the chronicity of the disease

    Time frame: through study completion, an average of 3 years

    lifestyle questionnaire assessing the impact on quality of life

Study contacts

Contact information is provided by the study sponsor or research team.

Brigitte Dreno, PU-PH

CONTACT

[email protected]

0240083118

Sponsors and collaborators

Lead sponsor

Nantes University Hospital

Other

Registry information

Acronym: COVER

Important dates

Study start
2022
Primary completion
2030
Study completion
2030
First posted
Apr 17, 2020
Registry last updated
Sep 5, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.